Pharmaplus Invest SRL
1.6 FTEPharmaplus Invest reported total assets of 976,007 € at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026), with 1.6 full-time equivalent.
The score of Pharmaplus Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -60 % Total assets -1 % Headcount (avg FTE) +33 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaplus Invest's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 59,853 € | ||||
| Equity | 72,734 € | ||||
| Cash | 528,512 € | ||||
| EBITDA | 201,039 € | ||||
| Total assets | 976,007 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Pharmaplus Invest's financial analysis
- Solvency7.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaplus Invest
Pharmaplus Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0505.864.007
- VAT number
- BE0505864007
- Peppol
- Registered · 0208:0505864007 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Dec 2014
- Registered office
- 1190 Forest
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmaplus Invest (SRL) has been based in Forest since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 59,853 € and equity of 72,734 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 7.5%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmaplus Invest
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie De Spiegeleere-Roosendael Retail sale of pharmaceutical products Forest · balance sheet 978,954 €
- Apotheek van der Burght Retail sale of pharmaceutical products Haaltert · balance sheet 975,475 €
- Pharmasambre Retail sale of pharmaceutical products Sambreville · balance sheet 977,337 €
- Medithera Retail sale of pharmaceutical products Rixensart · balance sheet 972,011 €
- Sybephar Retail sale of pharmaceutical products Oudenaarde · balance sheet 970,416 €
- Apoteek Ackerman A. Retail sale of pharmaceutical products Ghent · balance sheet 981,775 €
- Mentover Retail sale of pharmaceutical products Antwerp · balance sheet 981,994 €
- De Pourcq Farma Retail sale of pharmaceutical products Mechelen · balance sheet 987,151 €
Frequently asked questions about Pharmaplus Invest
What is the revenue of Pharmaplus Invest?
Pharmaplus Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaplus Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0505864007 for Pharmaplus Invest, if the company is VAT-registered. Its company number (CBE) is 0505.864.007.
Where is the registered office of Pharmaplus Invest?
According to the CBE register, the registered office of Pharmaplus Invest is in 1190 Forest.
What is the equity of Pharmaplus Invest?
At the close of the 2025 financial year, the equity of Pharmaplus Invest amounts to 72,734 €, a solvency of 7.5% of total assets.
How many people work at Pharmaplus Invest?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmaplus Invest?
The register lists 1 active mandates at Pharmaplus Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaplus Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →